- $16.84bn
- $18.18bn
- $5.91bn
- 85
- 76
- 40
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,066 | 1,467 | 3,449 | 9,051 | 5,914 |
Cost of Revenue | |||||
Gross Profit | 1,415 | 822 | 2,630 | 8,006 | 4,849 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,111 | 1,171 | 1,885 | 3,814 | 3,760 |
Operating Profit | 956 | 295 | 1,564 | 5,237 | 2,154 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 900 | 241 | 1,502 | 5,169 | 2,128 |
Provision for Income Taxes | |||||
Net Income After Taxes | 681 | 201 | 1,158 | 4,065 | 1,625 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 681 | 201 | 1,158 | 4,065 | 1,625 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 681 | 201 | 1,158 | 4,057 | 1,620 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.64 | 0.502 | 2.46 | 5.12 | 2.13 |
Dividends per Share | |||||
Special Dividends per Share |